This annual achievement award was established in 2016 to honor the memory and legacy of Dr. Mitchell A. Baran, founder and former Chairman of Monaghan Medical Corporation (USA) and the Trudell Medical Group (Global). The companies and their affiliates are leading innovators in the evidence-based delivery of aerosolized medications and airway clearance therapies, as well as other medical devices and services.
Throughout his long and distinguished career, Dr. Baran was unwavering in his commitment to the necessity of basing product development and subsequent application on a foundation of established scientific evidence, coupled with the clinical expertise of those using such devices. Respiratory devices developed under his tenure have had an impact on patient’s health in the US and across the globe.
An endowment has been established with the American Respiratory Care Foundation (ARCF) to recognize and honor individuals demonstrating clinical excellence and leadership in advocating and promoting the use of evidence-based, clinically sound practices for the delivery of aerosolized medications and/or the application of non-pharmacologic airway clearance therapies.
In the year the award is bestowed, recipients will receive a cash prize of $2,500, an engraved crystal trophy, round-trip coach airfare with two nights lodging and registration, to the Annual Congress of The American Association for Respiratory Care (AARC).
Eligibility and Nominating Procedure:
At the beginning of each calendar year, the ARCF will invite nominations for the Mitchell A. Baran award from the AARC’s Board of Directors. A call for nominations will also be posted in the online and print edition of Respiratory Care. The posting will mention Dr Baran’s legacy (as stated in the first 2 paragraphs of this document), and the nomination criteria. Eligible candidates will, at a minimum, possess the registered respiratory therapist (RRT) credential and be an active member of the AARC for a minimum of seven consecutive years. It is anticipated that nominees will also have a record of voluntary service to the AARC and/or related professional organizations, with special emphasis given to those individuals exhibiting demonstrable clinical leadership skills.
A completed nomination must include the following:
- A description of the nominee’s professional background (i.e. a current curriculum vitae)
- A detailed narrative describing the nominee’s achievements in advocating and promoting excellence in the delivery of aerosolized mediations, airway clearance therapy and the impact such activities have had on patients, their families, and other clinicians, and
- A brief notation on clinical research activities undertaken to further and strengthen the knowledge base of aerosol medicine and non-pharmacologic airway clearance therapy.
Completed nominations must be received by the ARCF Executive Office no later than June 1 of the calendar year in which the Completed nominations must be received by the ARCF Executive Office no later than June 1st of the calendar year in which the award is to be bestowed. The ARCF will then forward completed nominations to the membership of the AARC’s Board of Medical Advisors (BOMA), with an accompanying electronic ballot, for final determination of the recipient. BOMA members will be advised they must recuse themselves from voting in the event of any conflict of interest (whether actual or potentially perceived) they may have in regard to any nominee. A copy of the communication to BOMA and the list of nominees will also be forwarded to Monaghan Medical Corporation (MMC) for information purposes only (MMC will have no role in the process).
Upon selection, the nominee will be so notified and invited to attend the Award Ceremony, held in conjunction with the AARC’s Annual Congress. The recipient of the award will also be invited to attend the annual BOMA Reception for further recognition and accolades.
The ARCF will provide Monaghan Medical (sponsor of the award) with an annual accounting of the MAB Award endowment, including the balance, investment income, and disbursements. The date of such accounting to be set by the ARCF to coincide with the filing of its year’s end audited financial statements.
Any changes to the criteria or process for judging Award recipients, or the Award itself, must have prior written approval from Monaghan Medical.
- 2023—Shawna L. Strickland, PhD, CAE, RRT, RRT-NPS, RRT-ACCS, AE-C, FAARC
- 2022—Jie Li, PhD, RRT, RRT-ACCS, FAARC
- 2021—Lung Partners Team of Crouse Hospital
- 2020—Not Awarded
- 2019—Michael McPeck, RRT, FAARC
- 2018—Arzu Ari, PhD, RRT, PT, CPFT, FAARC
- 2017—Joseph L. Rau Jr., PhD, RRT, FAARC
- 2016—Gregory Burns, RRT
- 2015—Allison Anderson
- 2014—Kari Armstrong
- 2013—John W. Newhart, RRT, RCP
- 2012—Jinxiang Xi, PhD
- 2011—Maher Mubarak AlQuaimi
- 2010—Susan A. Roark
- 2009—Robert Chatburn, RRT-NPS, FAARC
- 2008—Arzu Ari, PhD
- 2007—Ken Thigpen, BS, RRT
- 2006—Lisa Cracchiolo, RRT
- 2005—Hui-Ling Lin, MS, RRT
- 2004—Kathy Ehlers, BA, RRT
- 2003—Christopher M. Piccuito, RRT
- 2002—Robert H. Estetter, RRT and Idichandi Idicula, MS, RRT
- 2001—Jason Higgins, RRT
- 2000—Christine Dillman, BA, RRT
- 1999—Dean R. Hess, PhD, RRT, FAARC
- 1998—Robert Dickerson, MS, RRT
- 1997—James B. Fink, MS, RRT and Rick Kita, RRT
- 1996—Michael McPeck, RRT
- 1995—James B. Fink, MS, RRT, RCP
- 1994—Robert Gorman, RRT
- 1993—Dean Hess, MEd, RRT
- 1992—Signe M. Renshaw
- 1991—Becky Dukart